INTRODUCTION
============

One of the most common inherited blood disorders is thalassemia major. It is caused by mutation in the gene responsible for the synthesis of the beta chain of adult hemoglobin. Red blood cell maturation leads to ineffective erythropoiesis.^[@B1]^ Chronic anemia, iron accumulation in the tissues resulting from the red blood cell destruction, repeated blood transfusion, and the use of iron chelators (all these factors) affect organs negatively.^[@B2]^

β-Thalassemia affects more than 42,000 newborns every year all over the world. Populations with the highest prevalence are the Mediterranean, Central Asia, Middle East, India, and the Far East.^[@B3]^

β-Thalassemia major has both systemic and ocular affections. β-Thalassemia affects both anterior and posterior segments of the eye. Ocular surface disorder with goblet cell loss and squamous metaplasia of the conjunctiva,^[@B4]^ abnormal conjunctival vessels, against-the-rule pattern astigmatism, steeper corneal curvature, cataract, and thicker lens are some of the anterior segment manifestations of β-thalassemia major. However, retinal pigment epithelium (RPE) degeneration, RPE hypertrophy, angioid streaks, venous tortuosity, and optic nerve head drusen are some posterior segment manifestations. Other manifestations include shorter axial length (AL),^[@B2]^ color blindness, and decrease in the visual acuity.

The aim of this study was to find the effect of β-thalassemia on the angle of anterior chamber (ACA), intraocular pressure (IOP), and the other globe parameters.

MATERIALS AND METHODS
=====================

The study included 84 eyes. Forty-two eyes of children with thalassemia major (18 male and 24 female) and 42 eyes of control healthy children of the same age-group (12 male and 30 female). The thalassemia major children are on blood transfusion iron-chelating agents. Informed consent was obtained from the parents after detailed information was given. The study protocol was approved by the declaration of Helsinki protocol.

Exclusion criteria included amblyopia, aphakia, strabismus, cataract surgery, history of corneal disease, and systemic disease effect on refractive errors.

Head circumference, height, and weight were recorded for all patients. Complete ophthalmologic examinations were performed for all participants, including the best corrected visual acuity (BCVA), slit lamp biomicroscopic examination, external eye examination, IOP by Goldmann applanation tonometery and fundoscopy.

Refraction
----------

Cycloplegic refraction (using 0.5% cyclopentolate hydrochloride) and the corneal astigmatism were determined using an auto kerato-refractometer. The final result was taken as the average of three consecutive readings.

Anterior Segment Optical Coherence Topography
---------------------------------------------

NIDEK RS-3000 retinal scan with anterior segment module was used for anterior segment optical coherence topography (AS-OCT) measurements. Patients, with undilated pupils, fixated to AS-OCT. The ACA line was used to image the nasal and temporal angle quadrants (180° and 0° meridians). Both the quality and centration of image should be sufficient for analysis. The central corneal thickness (CCT) was measured using the cornea radial scan pattern. The best images were selected for being analyzed to measure the CCT and ACA.

The ACA width was calculated by measuring the angle between the iris tangential line and the posterior corneal surface with its apex in the angle recess.

A-scan Ultrasonography
----------------------

A-scan ultrasonography was used for measurement of ocular components anterior chamber depth (ACD), lens thickness (LT), AL, and vitreous chamber depth (VCD). The monitor A&B scan biometer was used following corneal anesthesia with tetracaine HCL. The patients were requested to lay in a supine position and look at a far object to neutralize the accommodation effect on the measured LT. The fingers were used to hold the lids apart. Excessive pressure on the globe should be avoided. The measures were obtained by applying the probe tip to touch the cornea. Five measurements per eye were taken. Relative lens position is the relative position of the center of the lens which is calculated by adding half the LT to the ACD and then dividing the sum by the AL multiplied by 10 \[ACD + 0.5 × LT/AL × 10\].

The data were collected and then statistically analyzed by using Mann--Whitney test, independent *t* test, Chi-square test, and Spearman test.

RESULTS
=======

In this study, the mean age of thalassemia patients was 16.43 ± 3.99, and for the control group was16.29 ± 3.83. The height of thalassemia patients was significantly shorter than the control group with *p* value of 0.000. However, the head circumference in thalassemia group was more than the control group with *p* value of 0.000 ([Table 1](#T1){ref-type="table"}). An insignificant change was observed in best corrected visual acuity (BCVA) with *p* value of 0.306 ([Table 2](#T2){ref-type="table"}).

As regards the ACA, the temporal angle (T-ACA) in thalassemia patients was significantly narrower than the control group with *p* value of 0.008. While the nasal angle showed a nonsignificant narrowing with *p* value of 0.153 ([Table 2](#T2){ref-type="table"}), the angle of anterior chamber was positively correlated with height and negatively correlated with the head circumference and IOP. The IOP was statistically higher in thalassemia patients with *p* value of 0.000 ([Table 2](#T2){ref-type="table"}). The increased IOP was positively correlated with the head circumference and the LT. However, it was negatively correlated with T-ACA, AL, VCD, and ACD ([Figs 1](#F1){ref-type="fig"} to [5](#F5){ref-type="fig"}).

###### 

Demographic and general characteristics of participants

                       *Control group*   *Patient group*   *Test value*    *p value*   *Sig.*   
  -------------------- ----------------- ----------------- --------------- ----------- -------- ----
  Sex                  Male              12 (71.4%)        18 (57.1%)        0.622     0.430    NS
                       Female            30 (28.6%)        24 (42.9%)                           
  Age                  Mean ± SD         16.29 ± 3.83      16.43 ± 3.99    −0.097      0.924    NS
                       Range             10--21            9--21                                
  Height               Mean ± SD         153.71 ± 3.67     148.57 ± 2.65     4.252     0.000    HS
                       Range             149--159          143--151                             
  Head circumference   Mean ± SD         53.93 ± 0.76      55.67 ± 0.77    −6.051      0.000    HS
                       Range             53--55            54.5--57                             

###### 

Anterior chamber angles, corneal astigmatism, corneal thickness, intraocular pressure, and visual acuity in thalassemia patients and control group

                      *Control group*   *Patient group*      *Test value*             *p value*   *Sig.*   
  ------------------- ----------------- -------------------- ------------------------ ----------- -------- ----
  T-ACA               Mean ± SD         35.64 ± 2.30         33.23 ± 2.09               2.896     0.008    HS
                      Range             29.9--38.2           29.5--35.9                                    
  N-ACA               Mean ± SD         33.28 ± 3.47         31.64 ± 2.29               1.473     0.153    NS
                      Range             23.9--36.7           26.8--35.6                                    
  C.astig             Median (IQR)      −0.75 (−1 to −0.5)   −0.75 (−1.25 to −0.75)     0.601     0.635    NS
                      Range             −2.25 to −0.25       −1.75 to −0.25                                
  Axis                Median (IQR)      34.00 (13--113)      91.00 (76--100)            0.148     0.150    NS
                      Range             4--182               47--176                                       
  IOP                 Mean ± SD         12.07 ± 1.33         15.21 ± 1.12             −6.765      0.000    HS
                      Range             10--14               13--17                                        
  Corneal thickness   Mean ± SD         511.86 ± 8.75        510.64 ± 16.57             0.242     0.810    NS
                      Range             495--525             487--545                                      
  BCVA                Median (IQR)      0.00 (0--0)          0.00 (0--0.2)              0.205     0.306    NS
                      Range             0--0.2               0--0.3                                        

T-ACA, temporal anterior chamber angle; N-ACA, nasal anterior chamber angle; C.astig, corneal astigmatism; IOP, intraocular pressure; BC VA, best corrected visual acuity

AL, ACD and VCD were significantly shorter in in thalassemia group than the control group with *p* value = 0.000 for all ([Table 3](#T3){ref-type="table"}); AL, ACD, and VCD were positively correlated with the height and negatively correlated with the head circumference and IOP ([Figs 6](#F6){ref-type="fig"} to [17](#F17){ref-type="fig"}).

The lens was thicker in the thalassemia group than the control group with *p* value of 0.000 ([Table 3](#T3){ref-type="table"}). This increase in LT was positively correlated with the head circumference and IOP but negatively correlated with the height ([Table 4](#T4){ref-type="table"}). As regards relative lens position, no difference was found between both groups with *p* value of 0.090 ([Table 3](#T3){ref-type="table"}).
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###### 

Biometric parameters for the control and thalassemia groups

                           *Control group*   *Patient group*   *Test value*   *p value*   *Sig.*   
  ------------------------ ----------------- ----------------- -------------- ----------- -------- ----
  AL                       Mean ± SD         23.87 ± 0.41      22.56 ± 0.74     5.742     0.000    HS
                           Range             22.9--24.42       21.42--23.75                        
  ACD                      Mean ± SD         3.54 ± 0.17       2.89 ± 0.33      6.579     0.000    HS
                           Range             3.28--3.83        2.46--3.46                          
  Lens thickness           Mean ± SD         3.56 ± 0.14       3.96 ± 0.19    −6.310      0.000    HS
                           Range             3.24--3.78        3.66--4.25                          
  Vitreous chamber depth   Mean ± SD         16.03 ± 0.24      15.10 ± 0.21   10.960      0.000    HS
                           Range             15.75--16.43      14.83--15.45                        
  Relative lens position   Mean ± SD         2.22 ± 0.08       2.16 ± 0.10      1.763     0.090    NS
                           Range             2.05--2.34        2.01--2.32                          
  K1                       Mean ± SD         41.59 ± 1.52      42.88 ± 1.28   −2.419      0.023    S
                           Range             37.5--43          41.75--45.5                         
  K2                       Mean ± SD         42.44 ± 1.37      43.86 ± 1.50   −2.608      0.015    S
                           Range             39.65--44         42.25--47                           

AL, axial length; ACD, anterior chamber depth; K1, the flatter corneal curvature; K2, the steeper corneal curvature
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###### 

Correlation of the parameters with height, head circumference, and intraocular pressure (IOP)

                           *Height*   *H. Circum*   *IOP*                         
  ------------------------ ---------- ------------- --------- --------- --------- ---------
  Height                   --         --            −0.535      0.003   −0.463      0.013
  Head circumference       −0.535       0.003       --        --        −0.535      0.003
  IOP                      −0.463       0.013         0.501     0.007   --        --
  AL                         0.445      0.018       −0.501      0.007   −0.765      0.000
  ACD                        0.641      0.000       −0.663      0.000   −0.676      0.000
  Lens thickness           −0.484       0.009         0.609     0.001     0.657     0.000
  Vitreous chamber depth     0.477      0.010       −0.599      0.001   −0.725      0.000
  T-ACA                      0.407      0.032       −0.471      0.011   −0.427      0.024
  N-ACA                      0.464      0.013       −0.349      0.069   −0.338      0.078

AL, axial length; ACD, anterior chamber depth; IOP, intraocular pressure; T-ACA, temporal anterior chamber angle; N-ACA, nasal anterior chamber angle

Also, there was steeper corneal curvature in thalassemia group with *p* value of 0.023 and 0.015 (for K~1~ and K~2~, respectively). No significant change was observed in corneal thickness in both groups with *p* value of 0.810 ([Table 3](#T3){ref-type="table"}).

DISCUSSION
==========

Thalassemia major is a hereditary disease that affects those living in the Mediterranean area, including Egypt, especially with a high incidence of the consanguineous marriages. The disease needs long-lasting follow-up and treatment. It creates an economic and social problem. Many factors affect the life span and the systemic symptoms such as the patient\'s socioeconomic and environmental situation. The progression of the disease in patients with thalassemia major, frequent blood transfusions, and the usage of chelating agents could affect the systemic symptoms.^[@B5]^ So, it is important to study the effect of thalassemia in different countries.

In this study, ACA was reported to be narrower in thalassemia patients, T-ACA was statistically significant, but N-ACA was statistically nonsignificant. There were no references to other studies to compare these results with others. This narrowing in T-ACA may be due to the increased length thickness that bush iris anteriorly, leading to T-ACA narrowing in the same mechanism of narrowing the angle with age. The affection of temporal angle with sparing of nasal angle is not well understood. But this finding has been found by Chen et al.^[@B6]^ who reported that the temporal angle is the angle that narrows with age.

The corneal thickness in both groups was not statistically different. So the increased IOP in thalassemia patients reported in this study and in other studies was not due to the difference in pachymetery. But it may be due to steeper corneal curvature as explained by Nowroozzadeh et al.^[@B7]^ However, the increased IOP in thalassemia patients may be due to the short AL, ACD, and VCD and due to the thick lens as supported by the negative correlation between the IOP and AL, ACD, and VCD found in this study ([Figs 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Also, the positive correlation between the LT and IOP reinforces this hypothesis. The narrower T-ACA may play a role in the increased IOP because a negative correlation between IOP and T-ACA was found in this study ([Fig. 5](#F5){ref-type="fig"}).

Thalassemia major affects the biometric parameters of the globe. In this study, the AL, ACD, and VCD decreased in thalassemia patients. This matches with Khalaj et al.,^[@B8]^ Nowroozzadeh et al.,^[@B7]^ Heydarian et al.,^[@B9]^ and Elkitkat et al.^[@B10]^ All reported shorter AL and ACD of thalassemia patients. This can be due to the skeletal abnormality affecting the bony orbit as a result of the bone marrow expansion. Pereira and Allemann^[@B11]^ found a correlation between AL, ACD, VCD and the height in normal population. As thalassemia patients have shorter height, they have shorter AL, ACD, and VCD as a part of generalized growth retardation. This hypothesis was supported by the positive correlation between the AL, ACD, VCD, and the height found in my study ([Figs 6](#F6){ref-type="fig"} to [9](#F9){ref-type="fig"}).

This study demonstrated an increase in LT in thalassemia patients as reported in some studies.^[@B7]--[@B10]^ The cause of this is not well understood. It might be due to precipitation of iron in lens matter. Despite the lens was thicker in thalassemia patients compared to the control, the relative lens position did not show statistical difference in both groups. This is because the increased LT is compensated by the short AL and ACD.

The thalassemia patients had steeper corneal curvature than the control group, which has been reported by Nowroozzadeh et al.,^[@B7]^ Heydarian et al.,^[@B9]^ and Elkitkat et al.^[@B10]^ The cause of this steep cornea has not been understood yet, but the change in a bony orbit may be the cause or it may be a compensatory mechanism for short AL.

The steeper corneal curvature and the increased LT compensate shorter AL. So no statistical difference in BCVA.

CONCLUSION
==========

Thalassemia affects ACA, IOP, and the biometric globe parameters. Narrower T-ACA and increased IOP were found in thalassemia patients. Shorter AL, VCD, and ACD were reported. Also, steeper corneal curvature and thicker lens were found. The CCT and the relative lens position were the same in both thalassemia patients and control groups.
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